Challenges in beta(3)-adrenoceptor agonist drug development

被引：94

作者：

Arch, Jonathan R. S. ^{[1
]}

机构：

[1] Univ Buckingham, Clore Lab, Hunter St, Buckingham MK18 1EG, England

来源：

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM | 2011年 / 2卷 / 02期

关键词：

D O I：

10.1177/2042018811398517

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：59 / 64

页数：6

共 56 条

[1] Arch J. R. S., 2011, HDB EXPT PH IN PRESS
[2] The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology:: perspectives from β3-adrenoceptor agonists
Arch, Jonathan R. S.
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 378 (02) : 225 - 240
[3] THE BROWN ADIPOCYTE BETA-ADRENOCEPTOR
ARCH, JRS
[J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1989, 48 (02) : 215 - 223
[4] β3-adrenoceptor agonists:: potential, pitfalls and progress
Arch, JRS
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) : 99 - 107
[5] ATYPICAL BETA-ADRENOCEPTOR ON BROWN ADIPOCYTES AS TARGET FOR ANTI-OBESITY DRUGS
ARCH, JRS
AINSWORTH, AT
CAWTHORNE, MA
PIERCY, V
SENNITT, MV
THODY, VE
WILSON, C
WILSON, S
[J]. NATURE, 1984, 309 (5964) : 163 - 165
[6] BETA(3)-ADRENOCEPTOR AND ATYPICAL BETA-ADRENOCEPTOR
ARCH, JRS
KAUMANN, AJ
[J]. MEDICINAL RESEARCH REVIEWS, 1993, 13 (06) : 663 - 729
[7] Do low-affinity states of β-adrenoceptors have roles in physiology and medicine?
Arch, JRS
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) : 517 - 518
[8] ARCH JRS, 1984, INT J OBESITY, V8, P1
[9] beta(3) Receptors: role in cardiometabolic disorders
Bhadada, Shraddha V.
Patel, Bhoomika M.
Mehta, Anita A.
Goyal, Ramesh K.
[J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2011, 2 (02) : 65 - 79
[10] Evidence against β3-adrenoceptors or low affinity state of β1-adrenoceptors mediating relaxation in rat isolated aorta
Brahmadevara, N
Shaw, AM
MacDonald, A
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (01) : 99 - 106

← 1 2 3 4 5 6 →